Canopy Biosciences Launches New Technology Vastly Improving Sensitivity of Next Generation Sequencing
ST. LOUIS, March 29, 2019 — Canopy Biosciences™ LLC, a leading provider of gene editing and gene expression products and services, announced today the launch of RareSeq, a new error corrected sequencing service that vastly increases the sensitivity of genetic testing over traditional methods. This technology, exclusively licensed from Washington University and developed by Todd... Read more